Company intelligence / Profile preview
Granules Pharmaceuticals
Chantilly, Virginia, United Statesgranulespharma.com ↗
- Ownership
- Private
- Employees
- ~340
- Development stage
- Other
01
Overview
Granules Pharmaceuticals Inc., the US subsidiary of Granules India, specializes in development, manufacturing, and commercialization of complex oral solid dosage generic pharmaceuticals. As of March 2025, 34 ANDAs were filed (31 approved), with 43 products commercialized, covering multiple therapeutic areas with an emphasis on value-added and modified-release formulations.[2]
- Therapeutic areas
- EndocrinologyInfectious DiseasesPulmonologyCardiovascularNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Granules Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Granules Pharmaceuticals.